Latest Insider Transactions at Passage Bio, Inc. (PASG)
This section provides a real-time view of insider transactions for Passage Bio, Inc. (PASG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Passage BIO, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Passage BIO, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 20
2021
|
Jill M. Quigley Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,300
-0.44%
|
$39,000
$30.01 P/Share
|
|
Jan 14
2021
|
Jill M. Quigley Chief Operating Officer |
BUY
Open market or private sale
|
Direct |
16,298
+5.21%
|
$488,940
$30.1 P/Share
|
|
Mar 03
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
5,574,023
+25.16%
|
-
|
|
Feb 28
2020
|
Orbimed Advisors LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
373,300
+50.0%
|
$6,719,400
$18.0 P/Share
|